{"id":"W2593776441","doi":"10.1182/blood.v110.11.472.472","title":"Efficacy and Safety of Dasatinib in Patients with Chronic Myeloid Leukemia in Blast Phase Whose Disease Is Resistant or Intolerant to Imatinib: 2-Year Follow-Up Data from the START Program.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University","funders":"","keywords":"Dasatinib; Imatinib; Medicine; Internal medicine; Imatinib mesylate; Transplantation; Gastroenterology; Myeloid leukemia; Oncology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001241943,0.0003045303,0.0008468137,0.0004500922,0.0003216573,0.0005251712,0.000265047,0.0003860088,0.0007351773],"category_scores_gemma":[0.001336264,0.0001856274,0.0006937039,0.0006150043,0.0002475435,0.0004406193,0.0002736006,0.0006051086,0.0003627382],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004977093,"about_ca_system_score_gemma":0.0003714869,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001096866,"about_ca_topic_score_gemma":0.002016388,"domain_scores_codex":[0.9994325,0.000182736,0.00008298759,0.00008166827,0.0001503679,0.00006971003],"domain_scores_gemma":[0.9982536,0.0003444337,0.0007798443,0.0001155991,0.0001739072,0.0003326328],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.03791364,0.001428682,0.9176138,0.0002000382,0.001079869,0.0006343222,0.0002438867,0.000609445,0.005911877,0.00004613461,0.001699866,0.03261844],"study_design_scores_gemma":[0.003871095,0.01035616,0.9807804,0.00002195959,0.000548522,0.000760337,0.00008841289,0.0004649662,0.001252742,0.00003339796,0.001807153,0.00001482155],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9967856,0.001270688,0.00008924244,0.00005931033,0.000007047949,0.00005881556,0.001265225,0.000006672889,0.0004573404],"genre_scores_gemma":[0.9951886,0.0004648361,0.0001424764,0.00007907464,0.00002842867,0.00005859434,0.003685728,0.000003142921,0.0003489998],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001241943,"threshold_uncertainty_score":0.006568074,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02264431182172957,"score_gpt":0.2975425443278579,"score_spread":0.2748982325061284,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}